APRILE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 1.613
EU - Europa 1.410
AS - Asia 607
SA - Sud America 73
AF - Africa 11
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.718
Nazione #
US - Stati Uniti d'America 1.597
GB - Regno Unito 369
RU - Federazione Russa 356
CN - Cina 239
SG - Singapore 225
IE - Irlanda 198
SE - Svezia 101
UA - Ucraina 98
DE - Germania 90
IT - Italia 78
BR - Brasile 61
FR - Francia 48
HK - Hong Kong 39
VN - Vietnam 30
FI - Finlandia 27
KR - Corea 23
IN - India 14
PL - Polonia 13
CA - Canada 11
JP - Giappone 8
BD - Bangladesh 6
ES - Italia 6
ZA - Sudafrica 6
BE - Belgio 5
MX - Messico 5
AR - Argentina 4
LT - Lituania 4
TR - Turchia 4
AU - Australia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
MY - Malesia 3
NL - Olanda 3
PT - Portogallo 3
DZ - Algeria 2
ID - Indonesia 2
IQ - Iraq 2
PK - Pakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
PE - Perù 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.718
Città #
Southend 335
Dallas 236
Dublin 197
Fairfield 160
Singapore 114
Chandler 111
Ashburn 103
Woodbridge 102
Moscow 91
Jacksonville 80
Santa Clara 80
Wilmington 69
Beijing 64
Ann Arbor 61
Houston 59
Seattle 54
Cambridge 45
Hong Kong 39
Nanjing 32
Princeton 32
New York 30
Los Angeles 25
Seoul 23
Siena 20
Hefei 19
Munich 14
Boardman 13
The Dalles 13
Shanghai 11
São Paulo 11
Helsinki 10
Nanchang 10
Warsaw 10
Ho Chi Minh City 9
Nuremberg 9
Poplar 9
Atlanta 8
Columbus 8
Dong Ket 8
Tokyo 8
Buffalo 7
San Mateo 7
Zhengzhou 7
Council Bluffs 6
Denver 6
Hebei 6
London 6
San Diego 6
Tianjin 6
Brussels 5
Chennai 5
Florence 5
Hanoi 5
Johannesburg 5
Milan 5
Montreal 5
San Francisco 5
Shenyang 5
Stockholm 5
Brooklyn 4
Cagliari 4
Chicago 4
Guangzhou 4
Mexico City 4
Norwalk 4
Phoenix 4
Poggibonsi 4
Taizhou 4
Boston 3
Brno 3
Cascavel 3
Changsha 3
Düsseldorf 3
Hangzhou 3
Hyderabad 3
Orem 3
Redondo Beach 3
Vienna 3
Ankara 2
Arezzo 2
Arienzo 2
Augusta 2
Bengaluru 2
Bethesda 2
Brescia 2
Campi Bisenzio 2
Castiglion Fiorentino 2
Curitiba 2
Falkenstein 2
Frankfurt am Main 2
Haikou 2
Izmir 2
Jiaxing 2
Kansas City 2
Kunming 2
Leawood 2
Lisbon 2
Menlo Park 2
Miami 2
New Delhi 2
Totale 2.549
Nome #
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 270
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 257
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 248
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 233
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 222
BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial 215
Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients. 215
Peptide vaccines for hematological malignancies: a missed promise? 201
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy. 195
FLT3 inhibitors in the management of acute myeloid leukemia 195
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination 194
A solitary uterine relapse in T-cell Acute Lymphoblastic Leukaemia: CT features and pathologic correlation 193
Flow-cytometry evaluation of residual Leukemia Stem Cells in Chronic Myeloid Leukemia patients: feasibility and clinical application. 192
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 171
Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy 152
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion 151
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 147
null 130
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 101
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study 68
Totale 3.750
Categoria #
all - tutte 10.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 27 18 42 32 22 23 39
2021/2022229 24 16 12 27 14 11 11 7 10 27 23 47
2022/2023359 19 30 48 52 31 79 1 33 35 5 17 9
2023/2024275 12 7 27 4 5 75 109 11 0 5 2 18
2024/2025485 6 19 62 19 72 21 5 23 70 14 64 110
2025/20261.047 97 195 158 212 367 18 0 0 0 0 0 0
Totale 3.750